|
1
|
Sambasivan S: Epithelial ovarian cancer:
Review article. Cancer Treat Res Commun. 33:1006292022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lheureux S, Braunstein M and Oza AM:
Epithelial ovarian cancer: Evolution of management in the era of
precision medicine. CA Cancer J Clin. 69:280–304. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nougaret S, McCague C, Tibermacine H,
Vargas HA, Rizzo S and Sala E: Radiomics and radiogenomics in
ovarian cancer: A literature review. Abdom Radiol (NY).
46:2308–2322. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang X, Arai S, Song X, Reichart D, Du K,
Pascual G, Tempst P, Rosenfeld MG, Glass CK and Kurokawa R: Induced
ncRNAs allosterically modify RNA-binding proteins in cis to inhibit
transcription. Nature. 454:126–130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cech TR and Steitz JA: The noncoding RNA
revolution-trashing old rules to forge new ones. Cell. 157:77–94.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun T: Long noncoding RNAs act as
regulators of autophagy in cancer. Pharmacol Res. 129:151–155.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huarte M: The emerging role of lncRNAs in
cancer. Nat Med. 21:1253–1261. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Braga EA, Fridman MV, Moscovtsev AA,
Filippova EA, Dmitriev AA and Kushlinskii NE: LncRNAs in ovarian
cancer progression, metastasis, and main pathways: ceRNA and
alternative mechanisms. Int J Mol Sci. 21:88552020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang JY, Lu AQ and Chen LJ: LncRNAs in
ovarian cancer. Clin Chim Acta. 490:17–27. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang Z, Zhang F, Cai K and Xu J: LncRNA
HOXA-AS2 facilitates prostate cancer progression by inhibiting
miR-885-5p to upregulate KDM5B. Kidney Blood Press Res. 48:45–55.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang F, Wu D, Chen J, Chen S, He F, Fu H,
Wu Q, Liu S, Li X and Wang W: Long non-coding RNA HOXA-AS2 promotes
the migration, invasion and stemness of bladder cancer via
regulating miR-125b/Smad2 axis. Exp Cell Res. 375:1–10. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jiang L, Wu Z, Meng X, Chu X, Huang H and
Xu C: LncRNA HOXA-AS2 facilitates tumorigenesis and progression of
papillary thyroid cancer by modulating the miR-15a-5p/HOXA3 Axis.
Hum Gene Ther. 30:618–631. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ding J, Xie M, Lian Y, Zhu Y, Peng P, Wang
J, Wang L and Wang K: Long noncoding RNA HOXA-AS2 represses P21 and
KLF2 expression transcription by binding with EZH2, LSD1 in
colorectal cancer. Oncogenesis. 6:e2882017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu J, Li M and Zhang Y: Long noncoding RNA
HOXA-AS2 regulates the expression of SCN3A by sponging miR-106a in
breast cancer. J Cell Biochem. 120:14465–14475. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang Y, Xu J, Zhang S, An J, Zhang J,
Huang J and Jin Y: HOXA-AS2 promotes proliferation and induces
epithelial-mesenchymal transition via the miR-520c-3p/GPC3 Axis in
Hepatocellular Carcinoma. Cell Physiol Biochem. 50:2124–2138. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lian Y, Li Z, Fan Y, Huang Q, Chen J, Liu
W, Xiao C and Xu H: The lncRNA-HOXA-AS2/EZH2/LSD1 oncogene complex
promotes cell proliferation in pancreatic cancer. Am J Transl Res.
9:5496–5506. 2017.PubMed/NCBI
|
|
18
|
Guan X, Zong ZH, Chen S, Sang XB, Wu DD,
Wang LL, Liu Y and Zhao Y: The role of miR-372 in ovarian carcinoma
cell proliferation. Gene. 624:14–20. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta DeltaC(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Grada A, Otero-Vinas M, Prieto-Castrillo
F, Obagi Z and Falanga V: Research techniques made simple: Analysis
of collective cell migration using the wound healing assay. J
Invest Dermatol. 137:e11–e16. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang X, Huang M, Kong L and Li Y: miR-372
suppresses tumour proliferation and invasion by targeting IGF2BP1
in renal cell carcinoma. Cell Prolif. 48:593–599. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Y, Li F, Feng C, Wu T, Chen Y, Shah JA,
Wang F, Cai Y, Wang J and Jin J: MiR-372-3p functions as a tumor
suppressor in colon cancer by targeting MAP3K2. Front Genet.
13:8362562022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chan JJ and Tay Y: Noncoding RNA:RNA
regulatory networks in cancer. Int J Mol Sci. 19:13102018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang X, Yang B, She Y and Ye Y: The lncRNA
TP73-AS1 promotes ovarian cancer cell proliferation and metastasis
via modulation of MMP2 and MMP9. J Cell Biochem. 119:7790–7799.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fang W and Xia Y: LncRNA HLA-F-AS1
attenuates the ovarian cancer development by targeting
miR-21-3p/PEG3 axis. Anticancer Drugs. 33:671–681. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zheng ZJ, Liu Y, Wang HJ, Pang WW and Wang
Y: LncRNA SNHG17 promotes proliferation and invasion of ovarian
cancer cells through up-regulating FOXA1. Eur Rev Med Pharmacol
Sci. 24:9282–9289. 2020.PubMed/NCBI
|
|
28
|
Croce CM and Calin GA: miRNAs, cancer, and
stem cell division. Cell. 122:6–7. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kasinski AL and Slack FJ: Epigenetics and
genetics MicroRNAs en route to the clinic: Progress in validating
and targeting microRNAs for cancer therapy. Nat Rev Cancer.
11:849–864. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Di Leva G and Croce CM: The role of
microRNAs in the tumori-genesis of ovarian cancer. Front Oncol.
3:1532013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dahiya N, Sherman-Baust CA, Wang TL,
Davidson B, Shih IeM, Zhang Y, Wood W III, Becker KG and Morin PJ:
MicroRNA expression and identification of putative miRNA targets in
ovarian cancer. PLoS One. 3:e24362008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen R and He P: Long noncoding RNA
HOXA-AS2 accelerates cervical cancer by the miR-509-3p/BTN3A1 axis.
J Pharm Pharmacol. 73:1387–1396. 2021. View Article : Google Scholar : PubMed/NCBI
|
